A PRECISE, PRACTICAL APPROACH TO 4D BIO-FABRICATED TRANSPLANTABLE TISSUES AND ORGANS
Precise Bio is a regenerative medicine company that is advancing the use of bio-printed tissues and organs in patients in ophthalmology and is building a broad portfolio of R&D programs in additional medical disciplines.
The company’s commercial and R&D programs are based on its innovative 4D-bio-fabrication technology. This innovative platform comprises cell expansion, biomaterials, processes, printing technology and other critical technologies that are leading the way toward generating a robust pipeline of proprietary products with substantial clinical and commercial value.
The company’s robust technology platform allows it to advance its fabricated human cornea program concurrent with the development of other organs and tissues for use in ophthalmic indications. Moreover, the company’s technology overcomes multiple challenges in scalable, reproducible manufacturing of bio-printed tissues and organs. This positions Precise Bio for leadership in the field of regenerative medicine to address unmet needs in many indications which cannot be treated with donor tissue, or are limited by the number of available donor tissues and organs.
The company maintains offices, laboratories and production facilities in North Carolina, in the U.S. and in Shoham, Israel.